DASFREE: Treatment-Free Remission (TFR) After Discontinuation of Dasatinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and Deep Molecular Response (DMR).
Saved in:
| Title: | DASFREE: Treatment-Free Remission (TFR) After Discontinuation of Dasatinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and Deep Molecular Response (DMR). |
|---|---|
| Authors: | Shah, Neil P., García-Gutiérrez, J. Valentín, Jiménez-Velasco, Antonio, Larson, Sarah, Saussele, Susanne, Rea, Delphine, Mahon, François-Xavier, Levy, Moshe Yair, Gómez-Casares, María Teresa, Luciano, Luigia, Nicolini, Franck-Emmanuel, Mauro, Michael J., Sy, Oumar, Martin-Regueira, Patricia, Lipton, Jeffrey H. |
| Source: | Clinical lymphoma, myeloma & leukemia 2019 Supplement 1; Vol. 19. |
| Journal Info: | Publisher: Elsevier B.V. ISSN: 2152-2650 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2152-2669 |
|---|---|
| DOI: | 10.1016/j.clml.2019.07.253 |
